Company Vineet Laboratories Limited

VINEETLAB

INE505Y01010

Pharmaceuticals

Market Closed - NSE India S.E. 07:05:10 2026-10-14 am EDT			5-day change	1st Jan Change
38.59 ^INR	+1.74%		+5.29%	+4.92%

Aug. 25	Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
Jul. 21	Vineet Laboratories Limited Announces Cessation of Gaddam Venkata Ramana to Hold the Office of Managing Director, Effective July 21, 2026	CI

Business description: Vineet Laboratories Limited

Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.

Number of employees: 57

Sales by Activity: Vineet Laboratories Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Active Pharmaceuticals Ingredient and Intermediates	2.43B	1.91B	2.12B	1.51B	770M

See all business segments

Geographical breakdown of sales: Vineet Laboratories Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
India	2.42B	1.9B	2.03B	1.24B	750M
Unallocated	2.07M	8.53M	53.93M	33.97M	-
Export	8.73M	58K	35.86M	228M	-

See all geographic segments

Executive Committee: Vineet Laboratories Limited

Manager	Title	Age	Since
Satyanarayana Raju Bhupathiraju DFI	Director of Finance/CFO	76	2020-12-31
Pavani Srinivasa Rao HRO	Human Resources Officer	-	-
B V Ramakrishna AUD	Comptroller/Controller/Auditor	-	-

See VINEET LABORATORIES LIMITED governance

Composition of the Board of Directors: Vineet Laboratories Limited

Director	Title	Age	Since
Venkata Ramana Gaddam BRD	Director/Board Member	57	2016-11-09
Satyanarayana Raju Bhupathiraju BRD	Director/Board Member	76	2016-11-09
Dilip Vishnu Acharekar CHM	Chairman	73	2020-11-15
Alluri Ranga Raju BRD	Director/Board Member	52	-
Rajesh Kumar Kathulla BRD	Director/Board Member	-	2025-05-13
Premananda Reddy Vennapusa BRD	Director/Board Member	-	2025-09-14
Jasmin Kunal Tailor BRD	Director/Board Member	-	2025-11-08

Composition of the Board of Directors

Company details: Vineet Laboratories Limited

Vineet Laboratories Ltd.

5-5-160, Malleswari Nilayam

500074, Hyderabad

+91 40 2412 8833

http://www.vineetlabs.co.in

address Vineet Laboratories Limited(VINEETLAB)

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VINEET LABORATORIES LIMITED	+1.74%	+5.29%	-5.76%	-25.36%	7.67M
ELI LILLY AND COMPANY	+3.42%	+1.95%	+49.19%	+96.54%	1,040B
JOHNSON & JOHNSON	+1.19%	-2.56%	+31.95%	+59.86%	599B
ABBVIE INC.	+2.79%	+4.20%	+23.41%	+92.06%	485B
MERCK & CO., INC.	+1.95%	+1.58%	+71.25%	+39.28%	350B
ROCHE HOLDING AG	+2.74%	+2.58%	+29.04%	+46.46%	345B
NOVARTIS AG	+2.28%	+1.87%	+17.51%	+40.21%	272B
ASTRAZENECA PLC	+2.90%	+0.61%	-3.80%	+11.68%	244B
AMGEN INC.	+2.88%	+3.20%	+45.07%	+48.60%	223B
GILEAD SCIENCES, INC.	+2.03%	+3.14%	+27.84%	+91.24%	183B
Average	+2.35%	+2.53%	+28.57%	+50.06%	374.28B
Weighted average by Cap.	+2.53%	+2.31%	+36.24%	+67.35%